References
- Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501–506
- Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389–396
- Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991;98:467–471
- Benson WE, Shields JA, Tasman W, Crandall AS. Posterior scleritis: a cause of diagnostic confusion. Arch Ophthalmol. 1979;97:1482–1486
- Watson PG. Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophtalmol Soc U K. 1982;102:257–281
- Watson PG, Hayreh SS, Awdry PN. Episcleritis and scleritis, I. Br J Ophthalmol. 1968;52:278–279 contd
- Watson PG. The diagnosis and management of scleritis. Ophthalmology. 1980;87:716–720
- Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191
- McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology. 1999;106:2380–2386
- Honik G, Wong IG, Gritz DC. Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea. 2013;32:1562–1566
- Homayounfar G, Borkar DS, Tham VM, et al. Clinical characteristics of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Ocul Immunol Inflamm. 2014;35:491--497
- Homayounfar G, Nardone N, Borkar DS, et al. Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study. Am J Ophthalmol. 2013;156:752–758
- Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature Working G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516
- Grunwald L, Newcomb CW, Daniel E, et al. Risk of relapse in primary acute anterior uveitis. Ophthalmology. 2011;118:1911–1915
- Efron B, Tibshirani RJ. An introduction to the Bootstrap. In: Cox DR, Hinkley DV, Reid N, Rubin DB, Silverman BW, eds. Monographs on statistics and applied probability. New York: Chapman & Hall; 1993:124–140
- Leal C, Le Roux K, Rahmi A, et al. Scleritis, clinical features, etiologies and treatment: a case series of 32 patients. Rev Med Intern. 2014;35:491--497
- Machado Dde O, Curi AL, Bessa TF, et al. Posterior scleritis: clinical features, systemic association, treatment and evolution of 23 patients. Arq Brasil Oftalmol. 2009;72:321–326
- Cheung CM, Chee SP. Posterior scleritis in children: clinical features and treatment. Ophthalmology. 2012;119:59–65
- Biswas J, Mittal S, Ganesh SK, et al. Posterior scleritis: clinical profile and imaging characteristics. Indian J Ophthalmol. 1998;46:195–202
- Calthorpe CM, Watson PG, McCartney AC. Posterior scleritis: a clinical and histological survey. Eye. 1988;2 :267–277
- Tranos PG, Ong T, Nolan W, et al. Posterior scleritis presenting with annular choroidal detachment as a complication of herpes zoster ophthalmicus. Retina. 2003;23:716–717
- Burgos PI, Perkins EL, Pons-Estel GJ, et al. Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum. 2009;60:2757–2766
- Chandrakantan A, Ratanapanichkich P, Said M, et al. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant. 2005;20:1214–1221
- Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int. 2004;65:1842–1849
- Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, et al. Clinical features and presentation of posterior scleritis: a report of 31 cases. Ocul Immunol Inflamm. 2014;22:203–207